ALUNA

Updated Nov 2024 · AI-assisted, clinician-supervised

Protocol

Evidence-backed recommendations derived from your panel results. Prioritised by expected biomarker impact.

High priority

Nutrition

Increase omega-3 intake

Omega-3 Index is 5.2% — below the optimal 8–12% range. Dietary change or supplementation will move this marker.

  • Add 2 servings of fatty fish per week (salmon, sardines, mackerel)
  • Consider 2–3g EPA+DHA daily via a high-quality triglyceride-form fish oil
  • Retest at 6-month panel to confirm uptake

Supplementation

Vitamin D optimisation

Current level is 28 ng/mL. Your clinician recommends reaching 40–60 ng/mL given your indoor work schedule.

  • 4,000 IU vitamin D3 daily with the largest meal of the day
  • Take alongside 100–200 μg vitamin K2 MK-7 for calcium co-regulation
  • Morning sun exposure 15–20 min where possible through winter
Medium priority

Nutrition

Homocysteine management

Homocysteine at 11.4 μmol/L is above the optimal < 10 threshold. Methylation support often resolves this.

  • Ensure adequate methylated B12 (methylcobalamin) and methyl-folate intake
  • Increase intake of leafy greens, legumes, and eggs
  • Consider a methylated B-complex for 90 days, then retest

Training

Sustain cardiovascular training

ApoB, LDL-C, and triglycerides have all improved — consistent with your reported increase in Zone 2 cardio.

  • Maintain ≥ 150 min/week moderate-intensity cardio
  • Preserve 2× weekly resistance training for insulin sensitivity and muscle maintenance
  • No changes needed — current training load is working

Sleep

Protect sleep quality

Cortisol trending down and testosterone trending up are consistent with improved sleep. These gains are worth protecting.

  • Maintain consistent sleep/wake times (± 30 min)
  • Avoid screens 60 min before sleep or use blue-light filtering
  • Keep alcohol intake below 2 drinks per occasion — it reliably disrupts deep sleep architecture
Monitor

Monitoring

Track DHEA-S trend

DHEA-S has declined from 278 to 241 μg/dL across 12 months — within normal age-related drift, but worth watching.

  • No intervention required at this time
  • Continue monitoring at each panel
  • If decline accelerates below 200 μg/dL, discuss adrenal axis support with your clinician

About this protocol

These recommendations are generated from your panel data and reviewed by your Aluna clinician. They are intended to complement — not replace — your primary care physician. If you have an existing condition or take prescription medications, discuss any protocol changes with your doctor before starting.